Futures Mixed Ahead...
Health Care: Health Services
NeoGenomics Inc. (NEO: NASDAQ)
$3.99 -0.09 | -2.21%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 65.00K | -1.18M | -3.30M | -2.24M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -9.19M | -5.23M | -2.86M | -3.87M |
| (Increase) Decrease in Inventories | -657.00K | -315.00K | -285.00K | -110.34K |
| (Increase) Decrease In Other Current Assets | 96.00K | -55.00K | 12.00K | -21.09K |
| (Decrease) Increase In Payables | 1.44M | 1.67M | 95.00K | 1.09M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 46.00K | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | 3.85M | 3.02M | 2.87M | 2.60M |
| Net Cash From Continuing Operations | -492.00K | 69.00K | -2.05M | -1.50M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -492.00K | 69.00K | -2.05M | -1.50M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -3.65M | -897.00K | -916.00K | -963.74K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -3.65M | -897.00K | -916.00K | -963.74K |
| Issuance of Debt | 0.00 | 456.00K | 3.13M | 273.12K |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 511.00K | 3.48M | 180.00K | 5.76M |
| Repayment of Long-Term Debt | -2.19M | -1.58M | -1.37M | -1.40M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 5.06M | 0.00 | 500.00K | -1.00M |
| Net Cash From Financing Activities | 3.38M | 2.36M | 2.43M | 3.63M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -760.00K | 1.53M | -534.00K | 1.16M |
Portfolios with NEO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
Latest NEO Headlines from TheStreet
- 3 Health Care Stocks Under $10 to Watch 06.11.13 | 02:06 pm
- 5 Stocks Under $10 Set to Explode 02.14.13 | 01:02 pm
- Better Postage Solutions for Small Biz 08.04.08 | 12:08 pm
- Top Five Small-Caps 11.23.07 | 10:11 am
Press Releases for NEO
- NeoGenomics Schedules Its Q1 2013 Earnings Release For April 25, 2013 - PR Newswire 04.17.13 | 03:04 pm
- NeoGenomics Announces Pricing Of $9.5 Million Public Offering - PR Newswire 02.28.13 | 07:02 am
- NeoGenomics Schedules Its Q4 And Full Year 2012 Earnings Release For February 14, 2013 - PR Newswire 02.05.13 | 02:02 pm
- NeoGenomics Validates And Launches NeoSITEâ¿¢ Barrett's Esophagus FISH Test For Surveillance And Diagnosis Of High Grade Dysplasia/Esophageal Cancer - PR Newswire 12.17.12 | 07:12 am
Partner Headlines for NEO
